Related Experiment Videos
Ultrasound contrast agents: clinical applications
1Department of Radiology, Rikshospitalet, Oslo, Norway. j.a.jakobsen@labmed.uio.no
European Radiology
|August 25, 2001
Summary
Ultrasound contrast agents (USCA) are microbubble-based intravenous injections that enhance ultrasound imaging. Their effective use depends on agent properties, clinical application factors, and patient cooperation for disease diagnosis and follow-up.
Area of Science:
- Medical Imaging
- Biomedical Engineering
- Pharmacology
Background:
- Ultrasound contrast agents (USCA) are typically gas-filled microbubbles, smaller than red blood cells, used for intravenous injections.
- Currently, a limited number of USCA are commercially available, with several others undergoing clinical development.
Purpose of the Study:
- To review established and emerging ultrasound contrast agents.
- To discuss factors influencing the efficacy of USCA in improving ultrasound imaging.
- To outline the requirements for successful clinical application of USCA.
Main Methods:
- Review of existing literature and market-available USCA.
- Analysis of agents currently under clinical evaluation.
- Discussion of pharmacokinetic and pharmacodynamic properties of USCA.
- Examination of clinical application requirements for USCA.
Main Results:
- USCA effectiveness is contingent upon their pharmacokinetic and pharmacodynamic profiles.
- Successful implementation requires a multidisciplinary approach involving technical expertise, medical knowledge, appropriate equipment, and patient cooperation.
- USCA demonstrate potential across various vascular beds and parenchymal organs.
Conclusions:
- Ultrasound contrast agents can significantly enhance the detection, characterization, and follow-up of diseases.
- The clinical utility of USCA spans from head to foot, impacting diverse anatomical regions.
- Optimizing USCA application necessitates a comprehensive understanding of both the agents and the clinical context.